Sio Gene Therapies, Inc. (SIOX) Social Stream
Sio Gene Therapies Inc (SIOX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SIOX.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 5 | $8 | $6 | $7.4 | $2.16 | 242.59% |
The Trend in the Analyst Price Target
Over the past 27 weeks, SIOX's average price target has gone down $1.48.
SIOX reports an average of 244.22% for its upside potential over the past 36 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-19 | 5 | 8.0 | 6 | 7.40 | 2.22 | 233.33% |
| 2021-09-18 | 5 | 8.0 | 6 | 7.40 | 2.22 | 233.33% |
| 2021-09-11 | 5 | 8.0 | 6 | 7.40 | 2.19 | 237.9% |
| 2021-09-04 | 5 | 8.0 | 6 | 7.40 | 2.09 | 254.07% |
| 2021-08-28 | 5 | 8.0 | 6 | 7.40 | 2.20 | 236.36% |
| 2021-08-14 | 6 | 12.5 | 6 | 8.25 | 2.03 | 306.4% |
| 2021-08-07 | 6 | 12.5 | 7 | 8.42 | 2.03 | 314.78% |
| 2021-08-05 | 6 | 12.5 | 7 | 8.42 | 2.02 | 316.83% |
| 2021-08-01 | 6 | 12.5 | 7 | 8.42 | 2.04 | 312.75% |
| 2021-07-24 | 6 | 12.5 | 7 | 8.42 | 2.35 | 258.3% |
| 2021-07-17 | 6 | 12.5 | 7 | 8.42 | 2.27 | 270.93% |
| 2021-07-10 | 6 | 12.5 | 7 | 8.42 | 2.50 | 236.8% |
| 2021-07-03 | 6 | 12.5 | 7 | 8.42 | 2.60 | 223.85% |
| 2021-06-26 | 6 | 12.5 | 7 | 8.42 | 2.89 | 191.35% |
| 2021-06-13 | 5 | 12.5 | 7 | 8.50 | 2.49 | 241.37% |
| 2021-06-05 | 5 | 12.5 | 7 | 8.70 | 2.18 | 299.08% |
| 2021-05-22 | 5 | 12.5 | 7 | 8.70 | 2.19 | 297.26% |
| 2021-05-15 | 5 | 12.5 | 7 | 8.70 | 2.14 | 306.54% |
| 2021-05-08 | 5 | 12.5 | 7 | 8.70 | 2.67 | 225.84% |
| 2021-04-25 | 4 | 12.5 | 7 | 8.88 | 2.53 | 250.99% |
| 2021-04-17 | 4 | 12.5 | 7 | 8.88 | 2.45 | 262.45% |
| 2021-04-10 | 4 | 12.5 | 7 | 8.88 | 2.67 | 232.58% |
| 2021-04-03 | 4 | 12.5 | 7 | 8.88 | 2.85 | 211.58% |
| 2021-03-20 | 4 | 12.5 | 7 | 8.88 | 2.70 | 228.89% |
| 2021-03-13 | 4 | 12.5 | 7 | 8.88 | 2.82 | 214.89% |
| 2021-03-06 | 4 | 12.5 | 7 | 8.88 | 2.51 | 253.78% |
| 2021-02-27 | 4 | 12.5 | 7 | 8.88 | 2.64 | 236.36% |
| 2021-02-20 | 4 | 12.5 | 7 | 8.88 | 3.15 | 181.9% |
| 2021-02-13 | 4 | 12.5 | 7 | 8.88 | 3.31 | 168.28% |
| 2021-02-06 | 4 | 12.5 | 7 | 8.88 | 3.01 | 195.02% |
| 2021-01-30 | 4 | 12.5 | 7 | 8.88 | 2.53 | 250.99% |
| 2021-01-23 | 4 | 12.5 | 7 | 8.88 | 2.80 | 217.14% |
| 2021-01-16 | 4 | 12.5 | 7 | 8.88 | 2.86 | 210.49% |
| 2021-01-09 | 4 | 12.5 | 7 | 8.88 | 3.05 | 191.15% |
SIOX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.2 | 3 | 2 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
SIOX's average broker recommendation rating improved by 0.43 over the prior 35 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SIOX as an investment opportunity.
- Sio Gene Therapies Inc's upside potential (average analyst target price relative to current price) is higher than 92.39% of all US stocks.
- Sio Gene Therapies Inc's average analyst price target is greater than 13.77% of all US stocks.
- SIOX has a greater number of analysts covering the stock than 30.42% of stocks in the mid market cap category.
- Sio Gene Therapies Inc's variance in analysts' estimates is lower than 68.81% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Sio Gene Therapies Inc are GNCA, VECT and CASI.
Is SIOX a Buy, Hold or Sell? See the POWR Ratings now!